"At Sansum Clinic in Santa Barbara, CA, our mission is to provide an excellent healthcare experience, recognizing our first priority is the patients we serve."

During the past decade, Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara" are "Breast Cancer" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials), "Neurotoxicity" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara" in a lesser frequency.

Most popular intervention types in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara" are "Drug" (3 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ginkgo Biloba" (1 trials), "Placebo" (1 trials), "bicalutamide" (1 trials), "bortezomib" (1 trials) and "dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara" are 1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".